MIM
SVRA icon

MetLife Investment Management’s Savara SVRA Stock Holding History

MetLife Investment Management’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Sell
69,449
-9,102
-12% -$50.7K ﹤0.01% 1887
2025
Q4 		$474K Buy
78,551
+18,245
+30% +$89.4K ﹤0.01% 1814
2025
Q3 		$215K Sell
60,306
-15,327
-20% -$45.3K ﹤0.01% 2278
2025
Q2 		$172K Buy
75,633
+23,531
+45% +$64K ﹤0.01% 2265
2025
Q1 		$144K Sell
52,102
-6,947
-12% -$19.2K ﹤0.01% 2366
2024
Q4 		$181K Sell
59,049
-7,858
-12% -$27.4K ﹤0.01% 2350
2024
Q3 		$284K Buy
66,907
+14,883
+29% +$65.7K ﹤0.01% 2096
2024
Q2 		$210K Buy
52,024
+12,213
+31% +$54.3K ﹤0.01% 2211
2024
Q1 		$198K Sell
39,811
-8,805
-18% -$42.5K ﹤0.01% 2209
2023
Q4 		$228K Buy
48,616
+8,073
+20% +$30.9K ﹤0.01% 2164
2023
Q3 		$153K Hold
40,543
– – ﹤0.01% 2350
2023
Q2 		$130K Buy
+40,543
New +$95.3K ﹤0.01% 2531
2019
Q3 		– Sell
-15,700
Closed -$37.2K – 2394
2019
Q2 		$37.2K Hold
15,700
– – ﹤0.01% 2419
2019
Q1 		$116K Buy
+15,700
New +$118K ﹤0.01% 2262
2018
Q4 		– Sell
-13,047
Closed -$146K – 2591
2018
Q3 		$146K Hold
13,047
– – ﹤0.01% 2256
2018
Q2 		$148K Buy
+13,047
New +$131K ﹤0.01% 2062

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MetLife Investment Management's SVRA Position: Q1 2026 in Review

MetLife Investment Management reduced its Savara (SVRA) stake by 12% in Q1 2026, selling an estimated $50.7K and leaving 69,449 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

MetLife Investment Management first reported a position in SVRA in Q2 2018 and has held it in 16 quarters since. The position peaked at $474K in Q4 2025. 186 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

  • MetLife Investment Management held 69,449 shares of Savara worth $379K as of Q1 2026.
  • MetLife Investment Management sold 9,102 Savara shares in Q1 2026, an estimated $50.7K.
  • Savara made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1887 holding.
  • MetLife Investment Management first reported a position in Savara in Q2 2018 and has held it in 16 quarters since.
  • MetLife Investment Management's Savara position peaked at $474K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.